| Tag | Content |
|---|
EnhancerAtlas ID | HS093-20100 |
Organism | Homo sapiens |
Tissue/cell | HL-60 |
Coordinate | chr21:34619670-34620470 |
Target genes | |
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_11492 | chr21:34618740-34621020 | CD20 | | SE_18464 | chr21:34615384-34620800 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19346 | chr21:34619127-34620559 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_22967 | chr21:34619685-34620451 | CD8_primiary | | SE_39725 | chr21:34619634-34620678 | Jurkat | | SE_66450 | chr21:34619634-34620678 | Jurkat |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH21I033246 | chr21 | 34619000 | 34621110 |
|
Enhancer Sequence | CTCAGCCTCC AGAGTAGCTG GGATTACAAG CACACACCAC CATACCTGGC TCATTTTTTG 60
TACTTTTAGT AGAAATGTTT CACCATGTTG GCCAGGCTAG TCTCGAACTC CTGACCTCAA 120
GTGATCCACC CGCCTCAGCC TGCCAAGGTG CTGAGGTTAC AAGCATGAGC CACCACACCT 180
GGCCCCAGTG TTTTCTTAAT ACAGCAACTC CACCCCCTCA TTATAACCCA ATGTTCTTTT 240
GTGTGTGAAC ACCAAGTGTG CATGCACCTA GTACCCAAAG CTCAGAGGAG AAGACTAGAC 300
CCCAAGAACA GGCCTACCCC TTCTTTCTTT CCCTGTGACT CAAGTCAGTT CCCTAACACA 360
CTGTGTTAAC AGCCCCAGCT GTGTTACTTT TTCAATTTCC CACTTTACAA CGAGTTTCCA 420
AGAGAACCAT CTGGTCTCAG CTTCCTGTTG TAGGCTATGC GGGTGTGCAC GTGCTCATAC 480
ATGATTAGCA AAGTGGTAAG GATAACTGAA TCCCCCTGTG GCAAACAATT CGGATACGAC 540
ATTTGCTGGA TTTGTGTGCA TGTTTACGTA TGTGTATAAA CAGACATCTG TGTGTACACA 600
CAGAAAAGAA AGAAAATCAG AATTTATAGT TCATGGTATT TGGGTTGTTA AAGAATGCAT 660
ATTAAAGTAA CAGTGAGATA TGTTTCATGG CTCAAATGAT AAATATGAAA AATACATAAA 720
TATCCAGGTT TAGAGGGAAT ACAAAGAGTG TGCTTTGGCA TGGTCCATCT GAAGTAATTG 780
GCAGCATGTA TTAAAAACCT 800
|
